Skip to main content

Articles

Page 13 of 13

  1. Intracellular levels of glutathione are depleted in patients with acquired immunodeficiency syndrome in whom the risk of tuberculosis, particularly disseminated disease is many times that of healthy individual...

    Authors: Vishwanath Venketaraman, Tatanisha Rodgers, Rafael Linares, Nancy Reilly, Shobha Swaminathan, David Hom, Ariel C Millman, Robert Wallis and Nancy D Connell

    Citation: AIDS Research and Therapy 2006 3:5

    Content type: Research

    Published on:

  2. The objective of this study was to evaluate the safety of twice daily, intra-vaginal use of 0.5% PRO 2000 Gel for fourteen days in HIV un-infected women at lower as well as higher risk for HIV acquisition, in ...

    Authors: Joshi Smita, Dutta Soma, Bell Beverly, Profy Albert, Kuruc JoAnn, Gai Fang, Cianciola Missy, Soto-Torres Lydia, Panchanadikar Anjali, Risbud Arun, Mehendale Sanjay and Reynolds Steven J

    Citation: AIDS Research and Therapy 2006 3:4

    Content type: Research

    Published on:

  3. Partial or complete seroreversion for HIV-1, or incomplete antibody evolution are relatively rare events that have so far only been described in patients treated with HAART early after virus infection. Whether...

    Authors: Marion Cornelissen, Suzanne Jurriaans, Jan M Prins, Margreet Bakker and Antoinette C van der Kuyl

    Citation: AIDS Research and Therapy 2006 3:3

    Content type: Short report

    Published on:

  4. Protease inhibitors, particularly ritonavir, causes significant gastrointestinal disturbances such as nausea, even at low doses. This ritonavir-induced nausea could be related to its oxidative stress in the gu...

    Authors: Han Aung, Sangeeta Mehendale, Wei-Tien Chang, Chong-Zhi Wang, Jing-Tian Xie and Chun-Su Yuan

    Citation: AIDS Research and Therapy 2005 2:12

    Content type: Research

    Published on:

  5. Implementation of programs for the prevention of mother-to-child transmission (PMTCT) of HIV faces a variety of barriers and challenges. The assessment of these challenges has generally been conducted in large...

    Authors: Francis Bajunirwe and Michael Muzoora

    Citation: AIDS Research and Therapy 2005 2:10

    Content type: Research

    Published on:

  6. Episomal 2-long terminal repeat (LTR) HIV-1 cDNA, a by-product of HIV-1 infection, is used in clinical trials as a marker for ongoing viral replication. It would be useful to employ 2-LTR cDNA to monitor crypt...

    Authors: Chong Xu, Joseph A Politch, Kenneth H Mayer and Deborah J Anderson

    Citation: AIDS Research and Therapy 2005 2:9

    Content type: Research

    Published on:

  7. RNA and DNA aptamers specific for HIV-1 reverse transcriptase (RT) can inhibit reverse transcription in vitro. RNA aptamers have been shown to potently block HIV-1 replication in culture. We previously reported m...

    Authors: Timothy S Fisher, Pheroze Joshi and Vinayaka R Prasad

    Citation: AIDS Research and Therapy 2005 2:8

    Content type: Research

    Published on:

  8. Murine leukemia virus (MLV) vector particles can be pseudotyped with a truncated variant of the human immunodeficiency virus type 1 (HIV-1) envelope protein (Env) and selectively target gene transfer to human ...

    Authors: Sandra Siegert, Sonja Thaler, Ralf Wagner and Barbara S Schnierle

    Citation: AIDS Research and Therapy 2005 2:7

    Content type: Methodology

    Published on:

  9. The neurofilament is a major structural component of myelinated axons. Increased cerebrospinal fluid (CSF) concentrations of the light chain of the neurofilament protein (NFL) can serve as a sensitive indicato...

    Authors: Magnus Gisslén, Lars Rosengren, Lars Hagberg, Steven G Deeks and Richard W Price

    Citation: AIDS Research and Therapy 2005 2:6

    Content type: Research

    Published on:

  10. In Cambodia, nearly half of pregnant women attend antenatal care (ANC), which is an entry point of services for prevention of mother-to-child transmission of HIV (PMTCT). However, most of ANC services are prov...

    Authors: Koum Kanal, Thai Leang Chou, Ly Sovann, Yasuo Morikawa, Yumi Mukoyama and Kazuhiro Kakimoto

    Citation: AIDS Research and Therapy 2005 2:5

    Content type: Short report

    Published on:

  11. Observational studies have suggested that low serum vitamin levels are associated with increased mother-to-child transmission (MTCT) of HIV and increased preterm delivery. We aimed to determine the efficacy of...

    Authors: Edward J Mills, Ping Wu, Dugald Seely and Gordon H Guyatt

    Citation: AIDS Research and Therapy 2005 2:4

    Content type: Research

    Published on:

  12. Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a u...

    Authors: Karen S Slobod, Chris Coleclough, Scott A Brown, John Stambas, Xiaoyan Zhan, Sherri Surman, Bart G Jones, Amy Zirkel, Pamela J Freiden, Brita Brown, Robert Sealy, Mattia Bonsignori and Julia L Hurwitz

    Citation: AIDS Research and Therapy 2005 2:3

    Content type: Hypothesis

    Published on:

  13. Protease inhibitors (PIs) block HIV-1 maturation into an infectious virus particle by inhibiting the protease processing of gag and gag-pol precursor proteins. We have used a simple anti-HIV-1 p24 Western blot...

    Authors: Heather A Baird, Andre J Marozsan, Michael M Lederman, Alan Landay, Donna Mildvan, Daniel R Kuritzkes, Harold A Kessler and Eric J Arts

    Citation: AIDS Research and Therapy 2005 2:2

    Content type: Research

    Published on:

  14. RNA based antiviral approaches against HIV-1 are among the most promising for long-term gene therapy. These include ribozymes, aptamers (decoys), and small interfering RNAs (siRNAs). Lentiviral vectors are ide...

    Authors: Akhil Banerjea, Ming-Jie Li, Leila Remling, John Rossi and Ramesh Akkina

    Citation: AIDS Research and Therapy 2004 1:2

    Content type: Research

    Published on: